Sartorius Stedim Biotech S.A.
SDMHF
$192.00
$0.500.26%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 898.91M | 845.52M | 783.58M | 800.86M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 898.91M | 845.52M | 783.58M | 800.86M | |
| Cost of Revenue | 530.01M | 454.31M | 408.63M | 463.70M | |
| Gross Profit | 368.90M | 391.21M | 374.95M | 337.17M | |
| SG&A Expenses | 199.76M | 189.53M | 175.22M | 187.18M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -22.70M | 18.84M | 9.79M | -7.25M | |
| Total Operating Expenses | 743.97M | 699.12M | 634.88M | 683.18M | |
| Operating Income | 154.94M | 146.41M | 148.70M | 117.68M | |
| Income Before Tax | 90.45M | 104.98M | 121.44M | 43.60M | |
| Income Tax Expenses | 35.50M | 27.24M | 31.57M | -5.76M | |
| Earnings from Continuing Operations | 54.95M | 77.74M | 89.87M | 49.35M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | 116.40K | -- | 210.50K | -746.20K | |
| Net Income | 55.06M | 77.74M | 90.08M | 48.61M | |
| EBIT | 154.94M | 146.41M | 148.70M | 117.68M | |
| EBITDA | 161.69M | 234.82M | 230.15M | 130.69M | |
| EPS Basic | 0.57 | 0.78 | 0.93 | 0.50 | |
| Normalized Basic EPS | 0.68 | 0.66 | -- | 0.50 | |
| EPS Diluted | 0.57 | 0.78 | 0.93 | 0.50 | |
| Normalized Diluted EPS | 0.68 | 0.66 | -- | 0.50 | |
| Average Basic Shares Outstanding | 96.82M | 99.28M | 97.27M | 97.18M | |
| Average Diluted Shares Outstanding | 96.82M | 99.28M | 97.27M | 97.18M | |
| Dividend Per Share | 0.80 | -- | -- | 0.74 | |
| Payout Ratio | 0.00% | 97.96% | -- | 0.00% | |